During the recent Berkshire Hathaway annual meeting, CEO Greg Abel told shareholders that the conglomerate’s decisions on investments and acquisitions depend on several factors, highlighting price relative to risk as one of them. See related article: Details TBD: Berkshire’s Jain, …
J&J to Pay $5.5 Billion to Settle Talc-Related Cancer Claims
Johnson & Johnson on Monday said it agreed to a $5.5 billion commitment to resolve years of litigation related to claims that its talc products